California Public Employees Retirement System Cue Biopharma, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$10.9 - $14.53 $637,650 - $850,005	-58,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$11.2 - $16.09 $58,676 - $84,295	-5,239 Reduced 8.22%	58,500 $714,000
Q4 2020 Feb 02, 2021	SELL	$11.12 - $16.4 $36,128 - $53,283	-3,249 Reduced 4.85%	63,739 $797,000
Q3 2020 Nov 05, 2020	BUY	$15.05 - $23.54 $54,180 - $84,744	3,600 Added 5.68%	66,988 $1.01 Million
Q2 2020 Aug 12, 2020	BUY	$12.7 - $30.73 $627,227 - $1.52 Million	49,388 Added 352.77%	63,388 $1.55 Million
Q4 2019 Jan 27, 2020	BUY	$7.06 - $17.47 $98,840 - $244,579	14,000 New	14,000 $222,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $49.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account